BeiGene
ONC
#733
Rank
S$34.74 B
Marketcap
$299.00
Share price
-0.76%
Change (1 day)
67.74%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -$8.36

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -$8.14. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-$8.14
2022-$25.4428.21%
2021-$19.84-19.96%
2020-$24.7920.81%
2019-$20.5231.52%
2018-$15.60417.57%
2017-$3.01-37.16%
2016-$4.80158.95%
2015-$1.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.30-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.35-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA